Send the following on WhatsApp
Continue to ChatFinal Report of a Randomized Phase 1b Trial to Assess Sequencing of the E39 and E39' Vaccines to Optimize Long-term Antitumor Immunity in Folate Binding Protein (FBP)-Expressing Breast and Ovarian Tumors https://www.sages.org/meetings/annual-meeting/abstracts-archive/final-report-of-a-randomized-phase-1b-trial-to-assess-sequencing-of-the-e39-and-e39-vaccines-to-optimize-long-term-antitumor-immunity-in-folate-binding-protein-fbp-expressing-breast-and-ovarian-tu/